Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder: The UNITE Randomized Clinical Trial.
Saved in:
| Title: | Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder: The UNITE Randomized Clinical Trial. |
|---|---|
| Authors: | Lipton RB; Departments of Neurology, Psychiatry and Behavioral Sciences, and the Montefiore Headache Center, Albert Einstein College of Medicine, New York, New York., Ramirez Campos V; Teva Branded Pharmaceutical Products R&D Inc, West Chester, Pennsylvania., Roth-Ben Arie Z; Teva Pharmaceutical Industries Ltd, Tel Aviv, Israel., Galic M; Teva-Pharma, Produtos Farmacêuticos, Lda, Porto Salvo, Portugal., Mitsikostas D; Department of First Neurology, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece., Tassorelli C; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.; IRCCS Mondino Foundation, Pavia, Italy., Denysenko L; Department of Neurology, Jefferson Headache Center, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.; Department of Psychiatry and Human Behavior, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania., Cohen JM; Braeburn Inc, Plymouth Meeting, Pennsylvania. |
| Source: | JAMA neurology [JAMA Neurol] 2025 Jun 01; Vol. 82 (6), pp. 560-569. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40323613 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder: The UNITE Randomized Clinical Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lipton+RB%22">Lipton RB</searchLink>; Departments of Neurology, Psychiatry and Behavioral Sciences, and the Montefiore Headache Center, Albert Einstein College of Medicine, New York, New York.<br /><searchLink fieldCode="AU" term="%22Ramirez+Campos+V%22">Ramirez Campos V</searchLink>; Teva Branded Pharmaceutical Products R&D Inc, West Chester, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Roth-Ben+Arie+Z%22">Roth-Ben Arie Z</searchLink>; Teva Pharmaceutical Industries Ltd, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Galic+M%22">Galic M</searchLink>; Teva-Pharma, Produtos Farmacêuticos, Lda, Porto Salvo, Portugal.<br /><searchLink fieldCode="AU" term="%22Mitsikostas+D%22">Mitsikostas D</searchLink>; Department of First Neurology, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Tassorelli+C%22">Tassorelli C</searchLink>; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.; IRCCS Mondino Foundation, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Denysenko+L%22">Denysenko L</searchLink>; Department of Neurology, Jefferson Headache Center, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.; Department of Psychiatry and Human Behavior, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Cohen+JM%22">Cohen JM</searchLink>; Braeburn Inc, Plymouth Meeting, Pennsylvania. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101589536%22">JAMA neurology</searchLink> [JAMA Neurol] 2025 Jun 01; Vol. 82 (6), pp. 560-569. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589536 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6157 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686149%22">21686149 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Neurol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40323613 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jamaneurol.2025.0806 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 560 Titles: – TitleFull: Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder: The UNITE Randomized Clinical Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lipton RB – PersonEntity: Name: NameFull: Ramirez Campos V – PersonEntity: Name: NameFull: Roth-Ben Arie Z – PersonEntity: Name: NameFull: Galic M – PersonEntity: Name: NameFull: Mitsikostas D – PersonEntity: Name: NameFull: Tassorelli C – PersonEntity: Name: NameFull: Denysenko L – PersonEntity: Name: NameFull: Cohen JM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2025 Jun 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2168-6157 Numbering: – Type: volume Value: 82 – Type: issue Value: 6 Titles: – TitleFull: JAMA neurology Type: main |
| ResultId | 1 |
